EU Health Technology Assessment Reform 2026: Implications for Ireland (remapconsulting.com)

• EU HTA reform from 2026 mandates joint clinical assessments
• Ireland must adapt HIQA and NCPE processes
• Early dossier preparation recommended for market access

"The EU Health Technology Assessment (HTA) reform starting in 2026 will reshape how new medicines are evaluated, influencing Irish HTA processes and patient access. The article by Remap Consulting outlines how pharmaceutical companies and Irish authorities can prepare for the new joint EU assessments, which will be aligned with national assessments. This affects market access for new therapies in Ireland."